- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Nasopharyngeal carcinoma
- Meeting Date: March 2025
- Public Summary Document (PSD) March 2025 July 2025 PBAC Meetings - (PDF 2MB)
- Public Summary Document (PSD) March 2025 July 2025 PBAC Meetings - (Word 1.4MB
Related Public Summary Documents
